BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2876233)

  • 1. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.
    Cowley AJ; Stainer K; Wynne RD; Rowley JM; Hampton JR
    Lancet; 1986 Oct; 2(8510):770-2. PubMed ID: 2876233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
    Boccanelli A; Zachara E; Liberatore SM; Carboni GP; Prati PL
    Postgrad Med J; 1986; 62 Suppl 1():184-7. PubMed ID: 3534859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
    Richardson A; Bayliss J; Scriven AJ; Parameshwar J; Poole-Wilson PA; Sutton GC
    Lancet; 1987 Sep; 2(8561):709-11. PubMed ID: 2888942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
    Webster J; Petrie JC; Robb OJ; Witte K; Lovell HG
    J Hum Hypertens; 1987 Sep; 1(2):121-6. PubMed ID: 3333523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atenolol improves blood pressure control in patients taking captopril and frusemide.
    Potter JF; Beevers DG
    J Hum Hypertens; 1987 Sep; 1(2):127-30. PubMed ID: 3333524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
    Cowley AJ; Stainer K; Wynne RD; Rowley JM; Hampton JR
    Int J Cardiol; 1989 Sep; 24(3):311-6. PubMed ID: 2527829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmias during concurrent therapy with captopril and frusemide.
    Daniels AR
    N Z Med J; 1987 Nov; 100(835):695. PubMed ID: 3330600
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of captopril and ibopamine in mild to moderate heart failure.
    Dohmen HJ; Dunselman PH; Poole-Wilson PA
    Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
    Andrews R; Charlesworth A; Evans A; Cowley AJ
    Eur Heart J; 1997 May; 18(5):852-7. PubMed ID: 9152656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose, twice daily captopril and frusemide: a safe, effective and flexible third line treatment regimen for hypertension.
    Rademaker M; Corrie J; Lindsay BA; Flapan AD; Padfield PL
    J Hum Hypertens; 1989 Jun; 3(3):173-7. PubMed ID: 2671368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
    Cowley AJ; Stainer K; Fullwood L; Muller AF; Hampton JR
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S45-52; discussion 52-3. PubMed ID: 2145238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of captopril and flosequinan in patients with severe heart failure.
    Cowley AJ; Wynne RD; Swami A; Birkhead J; Skene A; Hampton JR
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):465-70. PubMed ID: 1450090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
    Domingo E; Gilabert MR; Alio J; Angel J; Soler-Soler J
    Cathet Cardiovasc Diagn; 1991 Oct; 24(2):93-8. PubMed ID: 1742791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
    Lewis BS; Rabinowitz B; Schlesinger Z; Caspi A; Markiewicz W; Rosenfeld T; Sclarovsky S; Ermer W
    Cardiology; 1999; 91(1):1-7. PubMed ID: 10393392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG; Gillen G; Dargie HJ
    Eur Heart J; 1988 Feb; 9(2):132-41. PubMed ID: 2832173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
    Magnani B; Magelli C
    Postgrad Med J; 1986; 62 Suppl 1():153-8. PubMed ID: 3534852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
    Just H; Drexler H; Taylor SH; Siegrist J; Schulgen G; Schumacher M
    Herz; 1993 Dec; 18 Suppl 1():436-43. PubMed ID: 8125424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term evaluation of treatment for chronic heart failure: a 1 year comparative trial of flosequinan and captopril.
    Cowley AJ; McEntegart DJ; Hampton JR; Barnett DB; Bexton RS; Boyle R; Hanley SP; Millar-Craig M; Morris GK; Nicholls AJ
    Cardiovasc Drugs Ther; 1994 Dec; 8(6):829-36. PubMed ID: 7742261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.